ArticlePilot and feasibility studies2020

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome.

Kimberly Legault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.